Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 47.10M
December 31, 2025 41.75M
June 30, 2025 142.80M
December 31, 2024 124.87M
June 30, 2024 0.00
December 31, 2023 0.00
June 30, 2023 9.744M
December 31, 2022 9.741M
June 30, 2022 -0.0058M
December 31, 2021 -0.006M
June 30, 2021 -0.0053M
December 31, 2020 -0.0041M
June 30, 2020 -0.0027M
December 31, 2019 -0.0028M
June 30, 2019 -0.0296M
December 31, 2018 -0.0576M
June 30, 2018 -0.0604M
December 31, 2017 -0.0598M
June 30, 2017 -0.0588M
December 31, 2016 -0.0595M
June 30, 2016 -0.0618M
December 31, 2015 -0.0678M
Date Value
June 30, 2015 -0.0768M
December 31, 2014 -0.0903M
June 30, 2014 -0.2392M
December 31, 2013 -0.3809M
June 30, 2013 -0.4448M
December 31, 2012 -0.5124M
June 30, 2012 -0.5343M
December 31, 2011 -0.5196M
June 30, 2011 -0.4322M
December 31, 2010 -0.1881M
June 30, 2010 -1.999M
December 31, 2009 -1.999M
June 30, 2009 0.00
December 31, 2008 0.00
June 30, 2008 0.00
December 31, 2007 0.00
June 30, 2007 0.00
December 31, 2006 0.00
June 30, 2006 0.9157M
December 31, 2005 0.9157M
June 30, 2005 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Percheron Therapeutics Ltd. -0.1533M
Starpharma Holdings Ltd. 6.828M
Mayne Pharma Group Ltd. 128.71M
Acrux Ltd. 2.883M
Zelira Therapeutics Ltd. 0.2041M